Jonathan Rothbard's most recent trade in 180 Life Sciences Corp was a trade of 300,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 8, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
180 Life Sciences Corp | Jonathan Rothbard | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
180 Life Sciences Corp | Jonathan Rothbard | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 6.14 per share. | 07 Apr 2021 | 24,307 | 560,449 | - | 6.1 | 149,245 | Common Stock |